Investment analysts at StockNews.com assumed coverage on shares of Edap Tms (NASDAQ:EDAP – Get Free Report) in a report issued on Wednesday. The brokerage set a “hold” rating on the medical equipment provider’s stock.
Edap Tms Stock Down 3.6 %
Shares of NASDAQ:EDAP opened at $2.39 on Wednesday. The company has a market capitalization of $88.68 million, a PE ratio of -3.68 and a beta of 0.37. The company has a debt-to-equity ratio of 0.08, a current ratio of 2.18 and a quick ratio of 1.46. The business has a fifty day moving average price of $2.43 and a two-hundred day moving average price of $2.59. Edap Tms has a 1 year low of $2.00 and a 1 year high of $8.50.
Institutional Inflows and Outflows
Institutional investors have recently made changes to their positions in the company. Millennium Management LLC lifted its holdings in Edap Tms by 218.5% during the 4th quarter. Millennium Management LLC now owns 48,915 shares of the medical equipment provider’s stock worth $108,000 after purchasing an additional 33,558 shares in the last quarter. BNP Paribas Financial Markets lifted its holdings in Edap Tms by 111.5% during the 4th quarter. BNP Paribas Financial Markets now owns 48,650 shares of the medical equipment provider’s stock worth $108,000 after purchasing an additional 25,650 shares in the last quarter. Jane Street Group LLC lifted its holdings in Edap Tms by 174.7% during the 4th quarter. Jane Street Group LLC now owns 31,361 shares of the medical equipment provider’s stock worth $69,000 after purchasing an additional 73,361 shares in the last quarter. Schonfeld Strategic Advisors LLC lifted its holdings in Edap Tms by 48.5% during the 4th quarter. Schonfeld Strategic Advisors LLC now owns 160,800 shares of the medical equipment provider’s stock worth $355,000 after purchasing an additional 52,500 shares in the last quarter. Finally, Rock Springs Capital Management LP lifted its holdings in Edap Tms by 1.5% during the 4th quarter. Rock Springs Capital Management LP now owns 1,591,800 shares of the medical equipment provider’s stock worth $3,518,000 after purchasing an additional 23,800 shares in the last quarter. Hedge funds and other institutional investors own 62.74% of the company’s stock.
About Edap Tms
EDAP TMS SA is a holding company, which, through its subsidiary, engages in the development, production, and marketing of minimally invasive medical devices for urological diseases. It operates through the High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS) segments. The HIFU segment develops, manufactures, and markets devices for the minimally invasive ablation of certain types of localized tumors using HIFU technology.
Read More
- Five stocks we like better than Edap Tms
- 3 REITs to Buy and Hold for the Long Term
- NVIDIA Stock Remains Stunningly Undervalued—Here’s Why
- What is the Dow Jones Industrial Average (DJIA)?
- Oracle Stock: 5 Reasons This AI Powerhouse Is a Long-Term Buy
- Using the MarketBeat Dividend Tax Calculator
- U.S. Stocks Sink, Foreign Markets Soar: 3 ETFs to Ride the Wave
Receive News & Ratings for Edap Tms Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Edap Tms and related companies with MarketBeat.com's FREE daily email newsletter.